posted on Oct, 7 2009 @ 09:54 AM
More on Panvax H1N1
Panvax® H1N1 Vaccine is a purified, inactivated, monovalent, split virion (split virus) vaccine. A single 0.5 mL dose contains antigen of the
A/California/7/2009 (H1N1) (NYMC X-179A) (A/California/7/2009 (H1N1)v-like)
15 μg haemagglutinin (HA) per dose
Each 0.5 mL dose contains, nominally: sodium chloride 4.1 mg, sodium phosphate – dibasic anhydrous 0.3 mg, sodium phosphate – monobasic 0.08 mg,
potassium chloride 0.02 mg, potassium phosphate – monobasic 0.02 mg, calcium chloride 1.5 μg and thiomersal 50 μg (for multi-dose vial
The following are present in each 0.5 mL dose: sodium taurodeoxycholate ≤ 5 μg, ovalbumin ≤ 1.0 μg, sucrose < 10 μg, neomycin ≤ 0.7 ng,
polymyxin B sulfate ≤ 0.11 ng and beta-propiolactone ≤ 1.4 ng.
The virus strain in this vaccine complies with the Australian Influenza Vaccine Committee (AIVC) decision, endorsing the World Health Organisation
recommended virus for the influenza A(H1N1) vaccine.
Panvax® H1N1 Vaccine is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. The virus is harvested from the
eggs, purified by zonal centrifugation, inactivated with beta-propiolactone and disrupted with sodium taurodeoxycholate to produce split virion
So no live virus...
Lets look at Flumist
Each pre-filled refrigerated FluMist sprayer contains a single 0.2 mL dose. Each 0.2 mL dose
contains 106.5-7.5 FFU of live attenuated influenza virus reassortants of each of the three strains:
A/South Dakota/6/2007 (H1N1) (an A/Brisbane/59/2007-like), A/Uruguay/716/2007 (H3N2) (an
A/Brisbane/10/2007-like), and B/Brisbane/60/2008 . Each 0.2 mL dose also contains 0.188 mg/dose
monosodium glutamate, 2.00 mg/dose hydrolyzed porcine gelatin, 2.42 mg/dose arginine,
13.68 mg/dose sucrose, 2.26 mg/dose dibasic potassium phosphate, 0.96 mg/dose monobasic
potassium phosphate, and